A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity

D.A. Rider; C.E.G. Havenith; R. de Ridder; J. Schuurman; C. Favre; J.C. Cooper; S.M. Walker; O. Baadsgaard; S. Marschner; J.G.J. van de Winkel; J. Cambier; P.W.H.I. Parren; D.R. Alexander

A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity

Translated title of the contribution: A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity

D.A. Rider, C.E.G. Havenith, R. de Ridder, J. Schuurman, C. Favre, J.C. Cooper, S.M. Walker, O. Baadsgaard, S. Marschner, J.G.J. van de Winkel, J. Cambier, P.W.H.I. Parren, D.R. Alexander

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity
Original language	Undefined/Unknown
Pages (from-to)	9945-9953
Number of pages	9
Journal	Cancer Research
Volume	67
Publication status	Published - 2007

Cite this

Rider, D. A., Havenith, C. E. G., de Ridder, R., Schuurman, J., Favre, C., Cooper, J. C., Walker, S. M., Baadsgaard, O., Marschner, S., van de Winkel, J. G. J., Cambier, J., Parren, P. W. H. I., & Alexander, D. R. (2007). A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity. Cancer Research, 67, 9945-9953.

@article{a49bc5c4f4ae41e1b590aa03900bd88a,

title = "A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity",

author = "D.A. Rider and C.E.G. Havenith and \{de Ridder\}, R. and J. Schuurman and C. Favre and J.C. Cooper and S.M. Walker and O. Baadsgaard and S. Marschner and \{van de Winkel\}, J.G.J. and J. Cambier and P.W.H.I. Parren and D.R. Alexander",

year = "2007",

language = "Undefined/Unknown",

volume = "67",

pages = "9945--9953",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

}

Rider, DA, Havenith, CEG, de Ridder, R, Schuurman, J, Favre, C, Cooper, JC, Walker, SM, Baadsgaard, O, Marschner, S, van de Winkel, JGJ, Cambier, J, Parren, PWHI & Alexander, DR 2007, 'A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity', Cancer Research, vol. 67, pp. 9945-9953.

TY - JOUR

T1 - A human CD4 monoclonal antibody for the treatment of T cell lymphoma combines inhibition of T cell signaling by a dual mechanism with potent Fc-dependent effector activity

AU - Rider, D.A.

AU - Havenith, C.E.G.

AU - de Ridder, R.

AU - Schuurman, J.

AU - Favre, C.

AU - Cooper, J.C.

AU - Walker, S.M.

AU - Baadsgaard, O.

AU - Marschner, S.

AU - van de Winkel, J.G.J.

AU - Cambier, J.

AU - Parren, P.W.H.I.

AU - Alexander, D.R.

PY - 2007

Y1 - 2007

M3 - Article

SN - 0008-5472

VL - 67

SP - 9945

EP - 9953

JO - Cancer Research

JF - Cancer Research

ER -